Sierra J. Stringfield

Sierra J. Stringfield

Auto-generated profile, based on publicly available information

Sierra J. Stringfield

Department of Neuroscience, University of Pittsburgh , Pittsburgh, PA 15213

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2017 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AMAric C. Madayag
Aric C. Madayag
SSSierra J. Stringfield
Sierra J. Stringfield
KRKathryn J. Reissner
Kathryn J. Reissner
CBCharlotte A. Boettiger
Charlotte A. Boettiger
DRDonita L Robinson
Donita L Robinson

17 July 2019 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
SSSierra J. Stringfield
Sierra J. Stringfield
AMAric C. Madayag
Aric C. Madayag
CBCharlotte A. Boettiger
Charlotte A. Boettiger
DRDonita L Robinson
Donita L Robinson
Nicotine exposure enhances Pavlovian conditioned approach (PCA), or the learned approach to reward-predictive cues. While females show elevated approach to conditioned stimuli compared to males, potentially indicating heightened addiction vulnerability, it is unknown how sex may interact with nicotine to influence approach behavior. Additionally, brain-derived neurotrophic factor (BDNF) levels can be altered significantly after repeated nicotine exposure, suggesting a potential mechanism contributing to nicotine-induced behavioral phenotypes. The present study investigated the role of sex on nicotine-induced changes to stimulus-response behavior and associated BDNF protein levels. Male and female rats were exposed to nicotine (0.4 mg/kg, subcutaneously) or saline 15 min prior to each PCA session. PCA training consisted of 29 sessions of 15 trials, in which a 30-s cue presentation ended concurrently with a sucrose reward (20% w/v in water, 100 μL), and a 120-s variable intertrial interval occurred between trials. Approach behavior to the cue and reward receptacle was recorded. Preference toward the reward receptacle indicated a goal-tracking phenotype, and preference toward the cue indicated a sign-tracking phenotype, demonstrating that the cue had gained incentive salience. Twenty-four hours after the last PCA session, brain tissue was collected and BDNF levels were measured in the basolateral amygdala, orbitofrontal cortex, and nucleus accumbens using Western blot analysis. Nicotine exposure enhanced both sign- and goal-tracking conditioned approach, and females showed elevated sign-tracking compared to males. There were no sex-by-drug interactions on conditioned approach. Day-to-day variability in conditioned approach was similar between sexes. In contrast to prior studies, neither repeated exposure to nicotine nor sex significantly affected BDNF expression. Drug-naïve females exhibited heightened sign-tracking compared to males, and nicotine enhanced conditioned approach similarly in males and females. Further, non-significant changes to BDNF expression in brain regions highly associated with PCA indicate that BDNF is unlikely to drive nicotine-enhanced conditioned behavior.

18 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EFEric W. Fish
Eric W. Fish
MKMichael C. Krouse
Michael C. Krouse
SSSierra J. Stringfield
Sierra J. Stringfield
JDJeffrey F. DiBerto
Jeffrey F. DiBerto
ERElliott Robinson
Elliott Robinson
CMC. J. Malanga
C. J. Malanga
Fragile X syndrome (FXS) is a leading cause of intellectual disability. FXS is caused by loss of function of the FMR1 gene, and mice in which Fmr1 has been inactivated have been used extensively as a preclinical model for FXS. We investigated the behavioral pharmacology of drugs acting through dopaminergic, glutamatergic, and cholinergic systems in fragile X (Fmr1-/Y) mice with intracranial self-stimulation (ICSS) and locomotor activity measurements. We also measured brain expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. Fmr1-/Y mice were more sensitive than wild type mice to the rewarding effects of cocaine, but less sensitive to its locomotor stimulating effects. Anhedonic but not motor depressant effects of the atypical neuroleptic, aripiprazole, were reduced in Fmr1-/Y mice. The mGluR5-selective antagonist, 6-methyl-2-(phenylethynyl)pyridine (MPEP), was more rewarding and the preferential M1 antagonist, trihexyphenidyl, was less rewarding in Fmr1-/Y than wild type mice. Motor stimulation by MPEP was unchanged, but stimulation by trihexyphenidyl was markedly increased, in Fmr1-/Y mice. Numbers of midbrain TH+ neurons in the ventral tegmental area were unchanged, but were lower in the substantia nigra of Fmr1-/Y mice, although no changes in TH levels were found in their forebrain targets. The data are discussed in the context of known changes in the synaptic physiology and pharmacology of limbic motor systems in the Fmr1-/Y mouse model. Preclinical findings suggest that drugs acting through multiple neurotransmitter systems may be necessary to fully address abnormal behaviors in individuals with FXS.

1 September 2017 in Neuropharmacology
Verified
Journal Article
Closed access
SSS.J. Stringfield
S.J. Stringfield
JHJ.A. Higginbotham
J.A. Higginbotham
RWR. Wang
R. Wang
ABA.L. Berger
A.L. Berger
RMR.J. McLaughlin
R.J. McLaughlin
RFR.A. Fuchs
R.A. Fuchs

5 March 2016 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
TSTatiana A. Shnitko
Tatiana A. Shnitko
STSarah C. Taylor
Sarah C. Taylor
SSSierra J. Stringfield
Sierra J. Stringfield
SZShannon L. Zandy
Shannon L. Zandy
RCRoberto U. Cofresí
Roberto U. Cofresí
DRDonita L Robinson
Donita L Robinson

1 May 2018 in Behavioural Brain Research
Verified
Journal Article
Closed access
SSSierra J. Stringfield
Sierra J. Stringfield
CBCharlotte A. Boettiger
Charlotte A. Boettiger
DRDonita L Robinson
Donita L Robinson